Cheelcare (CHER.V) on Thursday said it received Canadian Patent No. 3090535 covering core technologies underlying its Companion platform from the Canadian Intellectual Property Office.
The patent term extends 20 years from the original filing date. A corresponding U.S. patent related to Companion technologies was previously granted following a filing made on Aug. 18, 2020, it said.
"The patent protects core interface technologies that enable the Companion power assist system to securely integrate with a manual wheelchair while remaining portable and easy for users to operate independently," said the company in a statement. "Management believes the company's expanding intellectual property portfolio supports long-term product differentiation as reimbursement-supported access and commercial adoption continue to grow."
Shares of the company were last seen unchanged at $1.75 on the TSX Venture Exchange.